Schonfeld Strategic Advisors’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Buy |
67,926
+8,255
| +14% | +$169K | 0.01% | 1089 |
|
|
2025
Q1 | $1.19M | Buy |
59,671
+44,371
| +290% | +$888K | 0.01% | 1101 |
|
|
2024
Q4 | $408K | Sell |
15,300
-40,700
| -73% | -$1.08M | ﹤0.01% | 1427 |
|
|
2024
Q3 | $1.6M | Buy |
56,000
+4,753
| +9% | +$136K | 0.01% | 860 |
|
|
2024
Q2 | $1.12M | Sell |
51,247
-114,194
| -69% | -$2.49M | 0.01% | 1039 |
|
|
2024
Q1 | $3.66M | Buy |
165,441
+4,141
| +3% | +$91.7K | 0.02% | 629 |
|
|
2023
Q4 | $3.48M | Buy |
161,300
+13,270
| +9% | +$286K | 0.02% | 566 |
|
|
2023
Q3 | $2.5M | Buy |
148,030
+110,500
| +294% | +$1.87M | 0.02% | 653 |
|
|
2023
Q2 | $515K | Buy |
37,530
+11,786
| +46% | +$162K | ﹤0.01% | 1184 |
|
|
2023
Q1 | $585K | Sell |
25,744
-31,715
| -55% | -$721K | 0.01% | 1106 |
|
|
2022
Q4 | $1.35M | Sell |
57,459
-108,935
| -65% | -$2.56M | 0.01% | 995 |
|
|
2022
Q3 | $4.34M | Sell |
166,394
-1,369
| -0.8% | -$35.7K | 0.04% | 577 |
|
|
2022
Q2 | $3.68M | Buy |
167,763
+106,059
| +172% | +$2.33M | 0.04% | 512 |
|
|
2022
Q1 | $2.77M | Buy |
61,704
+20,590
| +50% | +$924K | 0.02% | 574 |
|
|
2021
Q4 | $1.76M | Sell |
41,114
-5,022
| -11% | -$215K | 0.02% | 683 |
|
|
2021
Q3 | $3.07M | Buy |
46,136
+18,723
| +68% | +$1.25M | 0.03% | 520 |
|
|
2021
Q2 | $2.01M | Sell |
27,413
-118
| -0.4% | -$8.65K | 0.02% | 673 |
|
|
2021
Q1 | $1.89M | Buy |
27,531
+19,531
| +244% | +$1.34M | 0.02% | 648 |
|
|
2020
Q4 | $538K | Sell |
8,000
-70,700
| -90% | -$4.75M | 0.01% | 976 |
|
|
2020
Q3 | $4.05M | Buy |
78,700
+63,200
| +408% | +$3.25M | 0.08% | 319 |
|
|
2020
Q2 | $584K | Buy |
+15,500
| New | +$584K | 0.02% | 711 |
|